The tumor suppressor miR-9 has been shown to inhibit the expression of ST6GAL1, resulting in reduced invasiveness of mouse HCC cells by inhibition of α-2,6-linked sialylation and integrin-β1/FAK signaling pathway [28]. The gene discussed is ST6GAL1; the disease is neoplasm.